Renal Cancer

Construction and evaluation of a prognostic model for metabolism-related genes in kidney renal clear cell carcinoma using TCGA database. January 23, 2025

Final Analysis of Post-Marketing Surveillance for Avelumab + Axitinib in Patients With Renal Cell Carcinoma in Japan. January 23, 2025

Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations. January 22, 2025

Medullary Renal Cell Carcinoma: A Case Study. January 22, 2025

Unmet needs in the management of patients with bilateral synchronous renal masses: the rationale for clinical decision-making. January 22, 2025

Clinical Applications of Microbiome in Renal Cell Carcinoma. January 21, 2025

Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study. January 21, 2025

Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC). January 20, 2025

Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON? January 20, 2025

Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on immunotherapy. January 17, 2025

First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia. January 17, 2025

Paediatric renal tumours: an update on challenges and recent developments. January 16, 2025

Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal. January 16, 2025

The Clinical Role of Hypoxia Inducible Factor (HIF) Inhibition in Renal Cancer: A Focus on Belzutifan. January 16, 2025

Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial. January 15, 2025

Efficacy of immune checkpoint inhibitors in renal cell carcinoma venous tumour thrombus shrinkage (UroCCR 128). January 15, 2025

Belzutifan for renal cell carcinoma: Balancing regulatory approval with societal and patient impact. January 14, 2025

Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma. January 14, 2025

Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial. January 14, 2025

Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Canc January 13, 2025

Page 1 of 459